The effect of vasoconstriction agent for FloTrac system (cardiac output measurement device by arterial blood pressure wave form)

The effect of vasoconstriction agent for FloTrac system (cardiac output measurement device by arterial blood pressure wave form) - The effect of vasoconstriction agent for FloTrac system

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000010936

Enrollment

Registered

2013-07-01

Start date

2012-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elective surgery patient over 20 yrs

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Planned arterial catheterization. Planned usage of vasoconstriction agent if necessary. Pulmonary artery catheter and/or transesophageal ultrasonic cardiography planned. Written informed consent

Exclusion criteria

Exclusion criteria: Diagnosis of moderate or severe arterial regargitation.(Except the patients who are expected to be corrected aortic regurgitation during surgery.) Treated by intra aortic baloon pumping. Pregnant woman. Body mass index more than 40. Body weight less than 40kg. Participation to other studies which influence the measurements of this study.

Design outcomes

Primary

Measure	Time frame
The difference of cardiac output measurements between FloTrac system and Ordinary cardiac output monitoring devices in anesthesia.	—

Secondary

Measure	Time frame
The existence of cardiac output measurements change in FloTrac system and Ordinary cardiac output monitoring devices in anesthesia.	—

Countries

Japan

Contacts

Public ContactRyuji Nakamura

Division of Clinical Medical Science, Graduate School of Biomedical Sciences, Hiroshima University Department of Anesthesiology and Critical Care

r-nacamura@hiroshima-u.ac.jp081-082-256-3234

Outcome results